A Pivotal Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS ® 250/50 Inhalation Powder/GSK in Healthy Volunteers
Condition: Bioequivalence Interventions: Drug: Test Product; Drug: Reference Product Sponsors: Respirent Pharmaceuticals Co Ltd.; BECRO Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 10, 2020 Category: Research Source Type: clinical trials
A Pilot Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS ® 250/50 Inhalation Powder/GSK in Healthy Volunteers
Condition: Bioequivalence Interventions: Drug: Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg/Respirent; Drug: ADVAIR DISKUS® 250/50 Sponsors: Respirent Pharmaceuticals Co Ltd.; BECRO Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 8, 2020 Category: Research Source Type: clinical trials